Food and Drug Administration (FDA) for chronic weight management in patients with obesity or overweight, and it has proven to be an effective weight loss aid: clinical trial participants who took Wegovy injections lost around 21% of their body weight at the highest dose (7.2mg per week), while those who took Wegovy pills lost an average of 14% of their body weight at the highest dose (25 mg per day)
These findings are also consistent with real-world data (retrospective data from electronic health records from the TriNetX Analytics Networks) showing no increased suicidal ideation with semaglutide use compared to nonGLP-1 RAs therapies [50]
Mechanistically, the TLR2/TLR4 proteins, which are members of the TLR family and are highly expressed in the synovial macrophages of GA patients, are first activated through the recognition of FAs
Its worth noting that no completed, large, head-to-head trial directly comparing Wegovy 7.2mg with Mounjaro 15mg exists yet
(2) KSI
Some people, like Sam, have always exercised and viewed GLP-1s as an extra push to help them reach their weight goals
